Showing results (391-400 of 630) with videos related to
Sort By:
Pageof 63
The Journal of Allergy and Clinical Immunology|November 10, 2015
Nocturnal eczema: Review of sleep and circadian rhythms in children with atopic dermatitis and future research directionsAnna B Fishbein, Olivia Vitaterna, Isabel M Haugh, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 10, 2018
Content and construct validity, predictors, and distribution of self-reported atopic dermatitis severity in US adultsJonathan I Silverberg, Zelma C Chiesa Fuxench, Joel M Gelfand, et al.Allergy|June 13, 2017
What's in a name? Atopic dermatitis or atopic eczema, but not eczema aloneJ I Silverberg, J P Thyssen, A S Paller, et al.The Journal of Allergy and Clinical Immunology. in Practice|June 23, 2019
Pain Is a Common and Burdensome Symptom of Atopic Dermatitis in United States AdultsJonathan I Silverberg, Joel M Gelfand, David J Margolis, et al.Dermatology and Therapy|July 22, 2023
Racial and Ethnic Differences in Sociodemographic, Clinical, and Treatment Characteristics Among Patients with Atopic Dermatitis in the United States and Canada: Real-World Data from the CorEvitas Atopic Dermatitis RegistryJonathan I Silverberg, Vivian Y Shi, Andrew Alexis, et al.The Journal of Investigative Dermatology|October 25, 2016
Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic DisorderPatrick M Brunner, Jonathan I Silverberg, Emma Guttman-Yassky, et al.Dermatology and Therapy|October 14, 2022
Clinical Efficacy of a Digital Intervention for Patients with Atopic Dermatitis: a Prospective Single-Center StudySigrídur Lára Gudmundsdóttir, Tommaso Ballarini, María L Ámundadóttir, et al.Dermatitis : Contact, Atopic, Occupational, Drug|June 27, 2021
Rapid Improvement of Itch Associated With Atopic Dermatitis With Abrocitinib Is Partially Independent of Overall Disease Improvement: Results From Pooled Phase 2b and 3 Monotherapy StudiesBrian S Kim, Jonathan I Silverberg, Sonja Ständer, et al.The Journal of Allergy and Clinical Immunology|August 27, 2019
Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritusJonathan I Silverberg, Andreas Pinter, Grazyna Pulka, et al.Diagnostics (Basel, Switzerland)|February 25, 2023
Dysregulated Levels of Circulating Autoantibodies against Neuronal and Nervous System Autoantigens in COVID-19 PatientsYael Lavi, Aristo Vojdani, Gilad Halpert, et al.Pageof 63